ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. [electronic resource]
Producer: 20170809Description: 488-96 p. digitalISSN:- 1546-170X
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Benzamides
- Cell Survival -- drug effects
- Databases, Factual
- Gene Expression Regulation, Neoplastic
- Gene Knockdown Techniques
- Glucose-6-Phosphate Isomerase
- Humans
- Immunoblotting
- Immunohistochemistry
- Male
- Mice
- Neoplasm Transplantation
- Nitriles
- Nuclear Receptor Coactivator 1 -- metabolism
- Nuclear Receptor Coactivator 3 -- metabolism
- Nuclear Receptor Subfamily 1, Group F, Member 3 -- antagonists & inhibitors
- Phenylthiohydantoin -- analogs & derivatives
- Piperazines -- pharmacology
- Propanols -- pharmacology
- Prostatic Neoplasms, Castration-Resistant -- genetics
- RNA, Messenger -- metabolism
- Real-Time Polymerase Chain Reaction
- Receptors, Androgen -- genetics
- Response Elements
- Tumor Stem Cell Assay
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.